A study explored patients with multiple relapsed or refractory multiple myeloma (MM) and their need for innovative treatments due to shorter survival rates.
Study Highlights Innovative Treatments for Relapsed/Refractory Multiple Myeloma
Tori Gustafson2024-01-31T15:43:56+00:00January 31st, 2024|multiple myeloma|Comments Off on Study Highlights Innovative Treatments for Relapsed/Refractory Multiple Myeloma